GTC Biotherapeutics (GTCB), an LFB Group Company, Announces Name Change to rEVO Biologics and Renewed Commitment to Evolving Recombinant Medicine
1/4/2013 9:24:20 AM
More...
|
GTC Biotherapeutics (GTCB) Granted Protection until 2027 on Broad Transgenic Protein Production Patent, and is Also Granted New Patent on Recombinant Anti-Thrombin Produced Transgenically
5/20/2011 8:36:02 AM
More...
|
Acquisition of GTC Biotherapeutics (GTCB) by LFB Biotechnologies Completed
12/6/2010 11:17:16 AM
More...
|
French Biotech LFB Biotechnologies to Buy GTC Biotherapeutics (GTCB); GTC Agrees to go Private for $.30 Per Share
11/8/2010 8:03:05 AM
More...
|
GTC Biotherapeutics (GTCB) Reports Third Quarter 2010 Financial Results
10/28/2010 12:41:59 PM
More...
|
GTC Biotherapeutics (GTCB) Reports Third Quarter 2010 Financial Results
10/27/2010 11:09:58 AM
More...
|
GTC Biotherapeutics (GTCB) to Host Third Quarter 2010 Earnings Call and Webcast on Wednesday, October 27, 2010
10/20/2010 10:18:20 AM
More...
|
LFB Biotechnologies Offers to Take GTC Biotherapeutics (GTCB) Private for $.28 Per Share for Total of $17 Million
10/19/2010 7:13:01 AM
More...
|
GTC Biotherapeutics (GTCB) Reports Second Quarter 2010 Financial Results
7/27/2010 8:30:13 AM
More...
|
GTC Biotherapeutics (GTCB) to Host Second Quarter 2010 Earnings Call and Webcast on Tuesday, July 27, 2010
7/21/2010 7:51:19 AM
More...
|
|